Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Pocius, Kristina
DOB: 20-JAN-1944 (Age: 82)
Gender: male
Address:
99218 Nagys Ridge
93234 West Marijaside (Lithuania)
ID: 5121-608381-9 (ECI)
Report
Date: 29-JUL-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Dr. Tomas Bakas
182 Savanorių pr.
LT-91200 Klaipėda (Lithuania)
Specimen
Collected: 29-JUL-2023

Chemistry

Test 29-JUL-2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 74.2 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.4 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 103.1 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.7 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 233.5 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 125.9 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 180.2 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 28.1 L 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 12.1 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All basic metabolic and renal parameters are within normal limits. Glycemic control is adequate. Lipid profile shows elevated total and LDL cholesterol and low HDL cholesterol, indicating increased cardiovascular risk. Recommend lipid-lowering therapy and lifestyle modification. No evidence of renal dysfunction or microalbuminuria. Regular follow-up advised.